In non-neoplastic cells, the p53 gene has been reported to inhibit GLUT-1 and GLUT-4, and the mutation in the p53 gene has been reported to accelerate glucose transport for tumor cells by increasing the function of GLUT (17,18). The gene discussed is SLC2A4; the disease is neoplasm.